TY - JOUR
T1 - Blockage of progestin physiology disrupts ovarian differentiation in XX Nile tilapia (Oreochromis niloticus)
AU - Zhou, Linyan
AU - Luo, Feng
AU - Fang, Xuelian
AU - Charkraborty, Tapas
AU - Wu, Limin
AU - Wei, Jing
AU - Wang, Deshou
N1 - Funding Information:
The authors cordially thank Prof. Yong Zhu from East Carolina University, North Carolina, for providing the zebrafish nuclear Pgr antibody. This work was supported by grants 31572597 , 31201986 , 91331119 and 31030063 from the National Natural Science Foundation of China ; grant 20130182130003 from the Specialized Research Fund for the Doctoral Program of Higher Education of China ; This work was also supported in part by Research Foundation of Talent Introduction of Southwest University, China ( SWU111003 ) and Fundamental Research Funds for the Central Universities, China ( XDJK2015A004 and XDJK2014B040 ) from Ministry of Education of China . The special fund of Chongqing key laboratory (CSTC) .
Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.
PY - 2016/4/22
Y1 - 2016/4/22
N2 - Previous studies indicated that maturation inducing hormone, 17α, 20β-Dihydroxy-4-pregnen-3-one (DHP), probably through nuclear progestin receptor (Pgr), might be involved in spermatogenesis and oogenesis in fish. To further elucidate DHP actions in teleostean ovarian differentiation, we analyzed the expression of pgr in the ovary of Nile tilapia (Oreochromis niloticus), and performed RU486 (a synthetic Pgr antagonist) treatment in XX fish from 5 days after hatching (dah) to 120dah. Tilapia Pgr was abundantly expressed in the follicular cells surrounding oocytes at 30 and 90dah. Continuous RU486 treatment led to the blockage of oogenesis and masculinization of somatic cells in XX fish. Termination of RU486 treatment and maintenance in normal condition resulted in testicular differentiation, and estrogen compensation in RU486-treated XX fish successfully restored oogenesis. In RU486-treated XX fish, transcript levels of female dominant genes were significantly reduced, while male-biased genes were evidently augmented. Meanwhile, both germ cell mitotic and meiotic markers were substantially reduced. Consistently, estrogen production levels were significantly declined in RU486-treated XX fish. Taken together, our data further proved that DHP, possibly through Pgr, might be essential in the ovarian differentiation and estrogen production in fish.
AB - Previous studies indicated that maturation inducing hormone, 17α, 20β-Dihydroxy-4-pregnen-3-one (DHP), probably through nuclear progestin receptor (Pgr), might be involved in spermatogenesis and oogenesis in fish. To further elucidate DHP actions in teleostean ovarian differentiation, we analyzed the expression of pgr in the ovary of Nile tilapia (Oreochromis niloticus), and performed RU486 (a synthetic Pgr antagonist) treatment in XX fish from 5 days after hatching (dah) to 120dah. Tilapia Pgr was abundantly expressed in the follicular cells surrounding oocytes at 30 and 90dah. Continuous RU486 treatment led to the blockage of oogenesis and masculinization of somatic cells in XX fish. Termination of RU486 treatment and maintenance in normal condition resulted in testicular differentiation, and estrogen compensation in RU486-treated XX fish successfully restored oogenesis. In RU486-treated XX fish, transcript levels of female dominant genes were significantly reduced, while male-biased genes were evidently augmented. Meanwhile, both germ cell mitotic and meiotic markers were substantially reduced. Consistently, estrogen production levels were significantly declined in RU486-treated XX fish. Taken together, our data further proved that DHP, possibly through Pgr, might be essential in the ovarian differentiation and estrogen production in fish.
UR - http://www.scopus.com/inward/record.url?scp=84962613611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962613611&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2016.03.045
DO - 10.1016/j.bbrc.2016.03.045
M3 - Article
C2 - 26993165
AN - SCOPUS:84962613611
SN - 0006-291X
VL - 473
SP - 29
EP - 34
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -